CareCloud, Inc. Segments Disclosure
| 19. | SEGMENT REPORTING |
From January 1, 2024 through April 30, 2024, the Chief Executive Officer (“CEO”) and Executive Chairman served as the Chief Decision Maker (“CODM”), organizing the Company, managing resource allocations and measuring performance among two operating and reportable segments: (i) Healthcare IT and (ii) Medical Practice Management. As of May 1, 2024, the Company’s President, CEO and Executive Chairman served as the CODM. Effective January 1, 2025, the Executive Chairman and the two Co-CEOs served as the CODM. We report our segment information based on the internal reporting used by management for making decisions and assessing performance as the source of our reportable segments.
The CODM evaluates the financial performance of the business units on the basis of revenue, certain individual and total operating expenses and operating income (loss), as shown below, excluding unallocated amounts, which are mainly corporate overhead costs, for assessing operating results and the allocation of resources. Our CODM does not evaluate operating segments using asset or liability information. The CODM uses segment revenue, certain segment operating expenses and segment operating income (loss), as shown below, to manage the segments, comparing actual results to forecasted amounts and investigating the reasons for significant variances. Currently, a focus is being placed on reducing costs and managing global headcount. The segment revenue and segment operating income (loss) is also used to assess the performance of personnel and in establishing their compensation.
The Healthcare IT segment includes technology-assisted revenue cycle management, SaaS solutions and professional and other services. The Medical Practice Management segment includes the management of three medical practices. Each segment is considered a reporting unit. The Company does not have intra-entity sales or asset transfers, however, there are intracompany bank transfers. The accounting policies of the segments are the same as those disclosed in the summary of significant accounting policies. The following tables present revenues, operating expenses and operating income (loss) by reportable segment for the years ended December 31, 2025 and 2024:
| Year Ended December 31, 2025 | ||||||||||||
| ($ in thousands) | ||||||||||||
| Healthcare IT | Medical Practice Management | Total | ||||||||||
| Net revenue | $ | 106,566 | $ | 13,933 | (a) | $ | 120,499 | |||||
| Operating expenses: | ||||||||||||
| Direct operating costs | 53,077 | 11,379 | 64,456 | |||||||||
| Selling and marketing | 4,789 | 29 | 4,818 | |||||||||
| General and administrative | 9,932 | 2,510 | 12,442 | |||||||||
| Research and development | 6,382 | 6,382 | ||||||||||
| Depreciation and amortization | 14,632 | 328 | 14,960 | |||||||||
| Restructuring costs | 154 | 154 | ||||||||||
| Total operating expenses | 88,966 | 14,246 | 103,212 | |||||||||
| Segment operating income (loss) | $ | 17,600 | $ | (313 | ) | 17,287 | ||||||
| Reconciliation of profit or loss (segment profit/loss): | ||||||||||||
| Unallocated corporate expenses | (5,944 | ) | ||||||||||
| Net interest expense | (81 | ) | ||||||||||
| Other expense | (265 | ) | ||||||||||
| Income before income taxes | $ | 10,997 | ||||||||||
| Year Ended December 31, 2024 | ||||||||||||
| ($ in thousands) | ||||||||||||
| Healthcare IT | Medical Practice Management | Total | ||||||||||
| Net revenue | $ | 96,405 | $ | 14,432 | (a) | $ | 110,837 | |||||
| Operating expenses: | ||||||||||||
| Direct operating costs | 49,945 | 10,897 | 60,842 | |||||||||
| Selling and marketing | 6,201 | 31 | 6,232 | |||||||||
| General and administrative | 9,093 | 1,911 | 11,004 | |||||||||
| Research and development | 3,781 | 3,781 | ||||||||||
| Depreciation and amortization | 13,813 | 329 | 14,142 | |||||||||
| Lease termination and restructuring costs | 596 | 596 | ||||||||||
| Total operating expenses | 83,429 | 13,168 | 96,597 | |||||||||
| Segment operating income | $ | 12,976 | $ | 1,264 | 14,240 | |||||||
| Reconciliation of profit or loss (segment profit/loss): | ||||||||||||
| Unallocated corporate expenses | (5,119 | ) | ||||||||||
| Net interest expense | (812 | ) | ||||||||||
| Other expense | (298 | ) | ||||||||||
| Income before income taxes | $ | 8,011 | ||||||||||
| (a) | This revenue represents fees based on our actual costs plus a percentage of the operating profit. |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 12, 2026 | Showing above |
| 2024 | Mar 13, 2025 | |
| 2023 | Mar 21, 2024 | |
| 2022 | Mar 2, 2023 | |
| 2021 | Mar 14, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Mar 20, 2019 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.